Vynleads (VYND) Return on Capital Employed (2021 - 2026)
Vynleads (VYND) posted Return on Capital Employed of 66.83% for Q1 2026, down 3.02% on a QoQ basis from 68.91% in Q4 2025, and down 3050.0% YoY from 2.27% in Q1 2025.
Vynleads (VYND) Return on Capital Employed (2021 - 2026) Analysis & Trends
Vynleads (VYND) has reported Return on Capital Employed for 6 consecutive years, with 66.83% the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 3050.0% year-over-year to 66.83%; the trailing twelve-month figure through Mar 2026 stood at 66.83% (down 3050.0% YoY), and the FY2025 full-year result was 73.68%, down 2097.0% from the prior year.
- Return on Capital Employed retreated to 66.83% in Q1 2026 per VYND's latest filing, from 68.91% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 97.33% in Q1 2025 to a low of 27.05% in Q3 2024.
- Median Return on Capital Employed over the past 5 years was 44.59% (2022), compared with a mean of 52.23%.
- Annual changes were most pronounced in 2025 — Return on Capital Employed soared 6765 bps — and 2026, when it slumped 3050 bps.
- A 5-year view of Return on Capital Employed shows it stood at 41.12% in 2022, then decreased by 26 bps to 30.25% in 2023, then soared by 200 bps to 90.77% in 2024, then fell by 24 bps to 68.91% in 2025, then slipped by 3 bps to 66.83% in 2026.
- Per Business Quant, the three latest VYND Return on Capital Employed figures stand at 66.83% (Q1 2026), 68.91% (Q4 2025), and 74.11% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 13.00% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 2.09% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 10.67% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | -163.65% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -4.23% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 21.81% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 4.73% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 4.60% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 2.23% |
| 10 | Vynleads | - | - | -2,028.00 | 66.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.83% |
| Dec 31, 2025 | 68.91% |
| Sep 30, 2025 | 74.11% |
| Jun 30, 2025 | 85.01% |
| Mar 31, 2025 | 97.33% |
| Dec 31, 2024 | 90.77% |
| Sep 30, 2024 | 27.05% |
| Jun 30, 2024 | 27.92% |
| Mar 31, 2024 | 29.68% |
| Dec 31, 2023 | 30.25% |
| Sep 30, 2023 | 34.86% |
| Jun 30, 2023 | 36.79% |
| Mar 31, 2023 | 36.78% |
| Dec 31, 2022 | 41.12% |
| Sep 30, 2022 | 44.59% |
| Jun 30, 2022 | 45.33% |
| Mar 31, 2022 | 50.62% |
| Dec 31, 2021 | 54.04% |
| Sep 30, 2021 | -0.09% |
| Jun 30, 2021 | 9.05% |